Riskpilot← Back to searchSign inGet full accessEnderlins Vård och Gård AB
ABActiveOrg 5569612608Tysättravägen 12Medical specialists activities · NACE 8622Est. 20140 employees
Revenue 2024
SEK 5K
+25% vs 2023
EBITDA margin
—
Equity ratio
17.7%
Financial strength
Net profit 2024
SEK -10K
+23% vs 2023
| Revenue | SEK 5K | +25% |
| EBITDA | — | — |
| Net profit | SEK -10K | +23% |
| Total assets | SEK 215K | -4% |
| Equity | SEK 38K | -22% |
| Employees | 0 | — |
Legal name
Enderlins Vård och Gård AB
Org number
5569612608
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
7 februari 2014
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-10-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva öppen, privat hälso- och sjukvård inklusive utveckling och undervisning, uthyrning av kontorslokal, förrådslokal, lagerlokal samt stallplatser, småskalig tillverkning, reparation och försäljning av gårds- och hantverksprodukter samt bedriva därmed förenlig verksamhet.
Address
Tysättravägen 12
Email
elzbieta.enderlin@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 4 | 5 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −44 | −1 | 19 | −3 | — |
| Depreciation & amort. | −10 | −10 | −10 | −10 | −10 |
| EBIT | −54 | −11 | 9 | −13 | −10 |
| Net financials | — | — | — | — | — |
| Profit before tax | −54 | −11 | 9 | −13 | −10 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −54 | −11 | 9 | −13 | −10 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 274 | 273 | 239 | 225 | 215 |
| Equity | 64 | 53 | 62 | 49 | 38 |
| Long-term debt | 172 | 188 | 166 | 166 | 166 |
| Short-term debt | 38 | 32 | 10 | 10 | 10 |
| Total debt | 210 | 220 | 176 | 176 | 176 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
17.7%
This company
38.2%
Market median
-54% vs market
20202024
Return on equity
-26.3%
This company
18.4%
Market median
-243% vs market
20202024
Net profit margin
-200.0%
This company
8.1%
Market median
-2569% vs market
20202024
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20202024
Debt / equity
4.66×
This company
0.62×
Market median
-652% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-11-01 – 2022-10-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-10-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-11-01 – 2020-10-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2020 | |
| Former (2) | ||
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Enderlins Vård och Gård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan-Kamil Rembisch | Deputy Board Member | 0 companies |
| Sven Christer Sundquist | Deputy Board Member | 0 companies |
| Elzbieta Antonina Enderlin | Board of Directors | 0 companies |
| Bert Ola Ivansson | Deputy Board Member | 0 companies |